Rifaximin for the Management of Colonic Diverticular Disease: far Beyond a Simple Antibiotic

Antonio Tursi; Carmelo Scarpignato; Giovanni Brandimarte; Francesco Di Mario; Angel Lanas

doi:10.15403/jgld.2014.1121.274.rif

Rifaximin for the Management of Colonic Diverticular Disease: far Beyond a Simple Antibiotic

Authors

Antonio Tursi Gastroenterology Service, ASL BAT, Andria, Italy
Carmelo Scarpignato Clinical Pharmacology & Digestive Pathophysiology Unit, Department of Medicine & Surgery, University of Parma, Italy
Giovanni Brandimarte Division of Internal Medicine and Gastroenterology, „Cristo Re” Hospital, Rome, Italy
Francesco Di Mario Gastroenterology Unit, Department of Medicine & Surgery, University of Parma, Parma, Italy
Angel Lanas Service of Digestive Diseases, University Clinic Hospital Lozano Blesa, University of Zaragoza, IIS Aragón, Zaragoza, Spain

DOI:

https://doi.org/10.15403/jgld.2014.1121.274.rif

Keywords:

Abstract

Downloads

Published

2018-12-24

How to Cite

Tursi A, Scarpignato C, Brandimarte G, Di Mario F, Lanas A. Rifaximin for the Management of Colonic Diverticular Disease: far Beyond a Simple Antibiotic. JGLD [Internet]. 2018 Dec. 24 [cited 2026 Jul. 16];27(4):351-5. Available from: https://www.jgld.ro/jgld/index.php/jgld/article/view/2